Subgroup analyses were made to evaluate the prognostic value of TNFSF13 in different tumors, and these results revealed that TNFSF13 was a hazardous prognostic indicator in 15 independent tumor cohorts including LGG and GBM, and TNFSF13 was also a favorable prognostic indicator in 18 independent tumor cohorts according to OS (Supplementary Figure S4C). Here, TNFSF13 is linked to glioblastoma.